Engelhardt, Britta; Comabella, Manuel; Chan, Andrew (2022). Multiple Sclerosis: Immunopathological heterogeneity and its implications. European journal of immunology, 52(6), pp. 869-881. Wiley-VCH 10.1002/eji.202149757
|
Text
Eur_J_Immunol_-_2022_-_Engelhardt_-_Multiple_Sclerosis_Immunopathological_heterogeneity_and_its_implications.pdf - Accepted Version Available under License Publisher holds Copyright. Download (2MB) | Preview |
Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS). For the past decades several immunomodulatory disease modifying treatments with multiple presumed mechanisms of action have been developed, but MS remains an incurable disease. Whereas high efficacy, at least in early disease, corroborates underlying immunopathophysiology, there is profound heterogeneity in clinical presentation as well as immunophenotypes that may also vary over time. In addition, functional plasticity in the immune system as well as in the inflamed central nervous system further contributes to disease heterogeneity. In this review, we will highlight immune-pathophysiological and associated clinical heterogeneity that may have an implication for more precise immunomodulatory therapeutic strategies in MS. This article is protected by copyright. All rights reserved.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DCR Unit Sahli Building > Forschungsgruppe Neurologie 04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology 04 Faculty of Medicine > Pre-clinic Human Medicine > Theodor Kocher Institute |
UniBE Contributor: |
Engelhardt, Britta, Chan, Andrew Hao-Kuang |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0014-2980 |
Publisher: |
Wiley-VCH |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
28 Apr 2022 09:45 |
Last Modified: |
28 Apr 2023 00:25 |
Publisher DOI: |
10.1002/eji.202149757 |
PubMed ID: |
35476319 |
Uncontrolled Keywords: |
precision medicine ⋅ immunotherapy ⋅ brain barriers ⋅ biomarkers ⋅ multiple sclerosis |
BORIS DOI: |
10.48350/169578 |
URI: |
https://boris.unibe.ch/id/eprint/169578 |
Actions (login required)
 |
Edit item |